Global mRNA Vaccine And Therapeutics Market Research Report 2025(Status and Outlook)

March 2025 | 229 pages | ID: GDB135597475EN
Bosson Research

Abstracts

Report Overview

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

This report provides a deep insight into the global mRNA Vaccine And Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Vaccine And Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Vaccine And Therapeutics market in any manner.

Global mRNA Vaccine And Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Argos Therapeutics

BioNTech

CureVac

eTheRNA

Ethris

In-Cell-Art

Moderna Therapeutics

Sangamo Therapeutics

Tiba Biotechnology

Translate Bio

Market Segmentation (by Type)

Infectious Disease

Cancer

Others

Market Segmentation (by Application)

Hospital

Research Institual

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the mRNA Vaccine And Therapeutics Market
• Overview of the regional outlook of the mRNA Vaccine And Therapeutics Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccine And Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of mRNA Vaccine And Therapeutics
1.2 Key Market Segments
  1.2.1 mRNA Vaccine And Therapeutics Segment by Type
  1.2.2 mRNA Vaccine And Therapeutics Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL MRNA VACCINE AND THERAPEUTICS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global mRNA Vaccine And Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global mRNA Vaccine And Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL MRNA VACCINE AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global mRNA Vaccine And Therapeutics Product Life Cycle
3.3 Global mRNA Vaccine And Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global mRNA Vaccine And Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Vaccine And Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers mRNA Vaccine And Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 mRNA Vaccine And Therapeutics Market Competitive Situation and Trends
  3.8.1 mRNA Vaccine And Therapeutics Market Concentration Rate
  3.8.2 Global 5 and 10 Largest mRNA Vaccine And Therapeutics Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MRNA VACCINE AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS

4.1 mRNA Vaccine And Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MRNA VACCINE AND THERAPEUTICS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global mRNA Vaccine And Therapeutics Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to mRNA Vaccine And Therapeutics Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL MRNA VACCINE AND THERAPEUTICS MARKET BY REGION

6.1 Global mRNA Vaccine And Therapeutics Market Size by Region
  6.1.1 Global mRNA Vaccine And Therapeutics Market Size by Region
  6.1.2 Global mRNA Vaccine And Therapeutics Market Size Market Share by Region
6.2 Global mRNA Vaccine And Therapeutics Sales by Region
  6.2.1 Global mRNA Vaccine And Therapeutics Sales by Region
  6.2.2 Global mRNA Vaccine And Therapeutics Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America mRNA Vaccine And Therapeutics Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America mRNA Vaccine And Therapeutics Market Size by Type
7.3 North America mRNA Vaccine And Therapeutics Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe mRNA Vaccine And Therapeutics Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe mRNA Vaccine And Therapeutics Market Size by Type
8.3 Europe mRNA Vaccine And Therapeutics Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type
9.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America mRNA Vaccine And Therapeutics Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America mRNA Vaccine And Therapeutics Market Size by Type
10.3 South America mRNA Vaccine And Therapeutics Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa mRNA Vaccine And Therapeutics Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa mRNA Vaccine And Therapeutics Market Size by Type
11.3 Middle East and Africa mRNA Vaccine And Therapeutics Market Size by Application

12 MRNA VACCINE AND THERAPEUTICS MARKET PRODUCTION BY REGION

12.1 Global Production of mRNA Vaccine And Therapeutics by Region(2020-2025)
12.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Region (2020-2025)
12.3 Global mRNA Vaccine And Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America mRNA Vaccine And Therapeutics Production
  12.4.1 North America mRNA Vaccine And Therapeutics Production Growth Rate (2020-2025)
  12.4.2 North America mRNA Vaccine And Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe mRNA Vaccine And Therapeutics Production
  12.5.1 Europe mRNA Vaccine And Therapeutics Production Growth Rate (2020-2025)
  12.5.2 Europe mRNA Vaccine And Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan mRNA Vaccine And Therapeutics Production (2020-2025)
  12.6.1 Japan mRNA Vaccine And Therapeutics Production Growth Rate (2020-2025)
  12.6.2 Japan mRNA Vaccine And Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China mRNA Vaccine And Therapeutics Production (2020-2025)
  12.7.1 China mRNA Vaccine And Therapeutics Production Growth Rate (2020-2025)
  12.7.2 China mRNA Vaccine And Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)

13 MRNA VACCINE AND THERAPEUTICS MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global mRNA Vaccine And Therapeutics Sales Market Share by Type (2020-2033)
13.3 Global mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2033)
13.4 Global mRNA Vaccine And Therapeutics Price by Type (2020-2033)

14 MRNA VACCINE AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global mRNA Vaccine And Therapeutics Market Sales by Application (2020-2033)
14.3 Global mRNA Vaccine And Therapeutics Market Size (M USD) by Application (2020-2033)
14.4 Global mRNA Vaccine And Therapeutics Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Argos Therapeutics
  15.1.1 Argos Therapeutics Basic Information
  15.1.2 Argos Therapeutics mRNA Vaccine And Therapeutics Product Overview
  15.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Product Market Performance
  15.1.4 Argos Therapeutics Business Overview
  15.1.5 Argos Therapeutics SWOT Analysis
  15.1.6 Argos Therapeutics Recent Developments
15.2 BioNTech
  15.2.1 BioNTech Basic Information
  15.2.2 BioNTech mRNA Vaccine And Therapeutics Product Overview
  15.2.3 BioNTech mRNA Vaccine And Therapeutics Product Market Performance
  15.2.4 BioNTech Business Overview
  15.2.5 BioNTech SWOT Analysis
  15.2.6 BioNTech Recent Developments
15.3 CureVac
  15.3.1 CureVac Basic Information
  15.3.2 CureVac mRNA Vaccine And Therapeutics Product Overview
  15.3.3 CureVac mRNA Vaccine And Therapeutics Product Market Performance
  15.3.4 CureVac Business Overview
  15.3.5 CureVac SWOT Analysis
  15.3.6 CureVac Recent Developments
15.4 eTheRNA
  15.4.1 eTheRNA Basic Information
  15.4.2 eTheRNA mRNA Vaccine And Therapeutics Product Overview
  15.4.3 eTheRNA mRNA Vaccine And Therapeutics Product Market Performance
  15.4.4 eTheRNA Business Overview
  15.4.5 eTheRNA Recent Developments
15.5 Ethris
  15.5.1 Ethris Basic Information
  15.5.2 Ethris mRNA Vaccine And Therapeutics Product Overview
  15.5.3 Ethris mRNA Vaccine And Therapeutics Product Market Performance
  15.5.4 Ethris Business Overview
  15.5.5 Ethris Recent Developments
15.6 In-Cell-Art
  15.6.1 In-Cell-Art Basic Information
  15.6.2 In-Cell-Art mRNA Vaccine And Therapeutics Product Overview
  15.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Product Market Performance
  15.6.4 In-Cell-Art Business Overview
  15.6.5 In-Cell-Art Recent Developments
15.7 Moderna Therapeutics
  15.7.1 Moderna Therapeutics Basic Information
  15.7.2 Moderna Therapeutics mRNA Vaccine And Therapeutics Product Overview
  15.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Product Market Performance
  15.7.4 Moderna Therapeutics Business Overview
  15.7.5 Moderna Therapeutics Recent Developments
15.8 Sangamo Therapeutics
  15.8.1 Sangamo Therapeutics Basic Information
  15.8.2 Sangamo Therapeutics mRNA Vaccine And Therapeutics Product Overview
  15.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Product Market Performance
  15.8.4 Sangamo Therapeutics Business Overview
  15.8.5 Sangamo Therapeutics Recent Developments
15.9 Tiba Biotechnology
  15.9.1 Tiba Biotechnology Basic Information
  15.9.2 Tiba Biotechnology mRNA Vaccine And Therapeutics Product Overview
  15.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Product Market Performance
  15.9.4 Tiba Biotechnology Business Overview
  15.9.5 Tiba Biotechnology Recent Developments
15.10 Translate Bio
  15.10.1 Translate Bio Basic Information
  15.10.2 Translate Bio mRNA Vaccine And Therapeutics Product Overview
  15.10.3 Translate Bio mRNA Vaccine And Therapeutics Product Market Performance
  15.10.4 Translate Bio Business Overview
  15.10.5 Translate Bio Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global mRNA Vaccine And Therapeutics Market Size by Type (M USD)
Table 4. Global mRNA Vaccine And Therapeutics Market Size by Application (M USD)
Table 5. mRNA Vaccine And Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global mRNA Vaccine And Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global mRNA Vaccine And Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global mRNA Vaccine And Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global mRNA Vaccine And Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine And Therapeutics as of 2024)
Table 11. Global Market mRNA Vaccine And Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers mRNA Vaccine And Therapeutics Manufacturing Sites and Area Served
Table 13. Manufacturers mRNA Vaccine And Therapeutics Product Type
Table 14. Global mRNA Vaccine And Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Vaccine And Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. mRNA Vaccine And Therapeutics Market Size Comparison by Region (M USD)
Table 26. Global mRNA Vaccine And Therapeutics Market Size by Region (2020-2033) & (M USD)
Table 27. Global mRNA Vaccine And Therapeutics Market Size Market Share by Region (2020-2033)
Table 28. Global mRNA Vaccine And Therapeutics Sales by Region (2020-2033) & (K Units)
Table 29. Global mRNA Vaccine And Therapeutics Sales Market Share by Region (2020-2033)
Table 30. North America mRNA Vaccine And Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 31. North America mRNA Vaccine And Therapeutics Sales by Country (2020-2033) & (K Units)
Table 32. North America mRNA Vaccine And Therapeutics Sales by Type (K Units)
Table 33. North America mRNA Vaccine And Therapeutics Market Size by Type (M USD)
Table 34. North America mRNA Vaccine And Therapeutics Sales (K Units) by Type (2020-2033)
Table 35. North America mRNA Vaccine And Therapeutics Market Size (M USD) by Type (2020-2033)
Table 36. North America mRNA Vaccine And Therapeutics Sales by Application (K Units)
Table 37. North America mRNA Vaccine And Therapeutics Market Size by Application (M USD)
Table 38. North America mRNA Vaccine And Therapeutics Sales (K Units) by Application (2020-2033)
Table 39. North America mRNA Vaccine And Therapeutics Market Size (M USD) by Application (2020-2033)
Table 40. Europe mRNA Vaccine And Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 41. Europe mRNA Vaccine And Therapeutics Sales by Country (2020-2033) & (K Units)
Table 42. Europe mRNA Vaccine And Therapeutics Sales by Type (K Units)
Table 43. Europe mRNA Vaccine And Therapeutics Market Size by Type (M USD)
Table 44. Europe mRNA Vaccine And Therapeutics Sales (K Units) by Type (2020-2033)
Table 45. Europe mRNA Vaccine And Therapeutics Market Size (M USD) by Type (2020-2033)
Table 46. Europe mRNA Vaccine And Therapeutics Sales by Application (K Units)
Table 47. Europe mRNA Vaccine And Therapeutics Market Size by Application (M USD)
Table 48. Europe mRNA Vaccine And Therapeutics Sales (K Units) by Application (2020-2033)
Table 49. Europe mRNA Vaccine And Therapeutics Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific mRNA Vaccine And Therapeutics Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific mRNA Vaccine And Therapeutics Sales by Type (K Units)
Table 53. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (M USD)
Table 54. Asia-Pacific mRNA Vaccine And Therapeutics Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific mRNA Vaccine And Therapeutics Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific mRNA Vaccine And Therapeutics Sales by Application (K Units)
Table 57. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (M USD)
Table 58. Asia-Pacific mRNA Vaccine And Therapeutics Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific mRNA Vaccine And Therapeutics Market Size (M USD) by Application (2020-2025)
Table 60. South America mRNA Vaccine And Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 61. South America mRNA Vaccine And Therapeutics Sales by Country (2020-2033) & (K Units)
Table 62. South America mRNA Vaccine And Therapeutics Sales by Type (K Units)
Table 63. South America mRNA Vaccine And Therapeutics Market Size by Type (M USD)
Table 64. South America mRNA Vaccine And Therapeutics Sales (K Units) by Type (2020-2033)
Table 65. South America mRNA Vaccine And Therapeutics Market Size (M USD) by Type (2020-2033)
Table 66. South America mRNA Vaccine And Therapeutics Sales by Application (K Units)
Table 67. South America mRNA Vaccine And Therapeutics Market Size by Application (M USD)
Table 68. South America mRNA Vaccine And Therapeutics Sales (K Units) by Application (2020-2033)
Table 69. South America mRNA Vaccine And Therapeutics Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa mRNA Vaccine And Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa mRNA Vaccine And Therapeutics Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa mRNA Vaccine And Therapeutics Sales by Type (K Units)
Table 73. Middle East and Africa mRNA Vaccine And Therapeutics Market Size by Type (M USD)
Table 74. Middle East and Africa mRNA Vaccine And Therapeutics Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa mRNA Vaccine And Therapeutics Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa mRNA Vaccine And Therapeutics Sales by Application (K Units)
Table 77. Middle East and Africa mRNA Vaccine And Therapeutics Market Size by Application (M USD)
Table 78. Middle East and Africa mRNA Vaccine And Therapeutics Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa mRNA Vaccine And Therapeutics Market Size (M USD) by Application (2020-2033)
Table 80. Global mRNA Vaccine And Therapeutics Production (K Units) by Region(2020-2025)
Table 81. Global mRNA Vaccine And Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 82. Global mRNA Vaccine And Therapeutics Revenue Market Share by Region (2020-2025)
Table 83. Global mRNA Vaccine And Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America mRNA Vaccine And Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe mRNA Vaccine And Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan mRNA Vaccine And Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China mRNA Vaccine And Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global mRNA Vaccine And Therapeutics Sales by Type (K Units)
Table 89. Global mRNA Vaccine And Therapeutics Market Size by Type (M USD)
Table 90. Global mRNA Vaccine And Therapeutics Sales (K Units) by Type (2020-2033)
Table 91. Global mRNA Vaccine And Therapeutics Sales Market Share by Type (2020-2033)
Table 92. Global mRNA Vaccine And Therapeutics Market Size (M USD) by Type (2020-2033)
Table 93. Global mRNA Vaccine And Therapeutics Market Size Share by Type (2020-2033)
Table 94. Global mRNA Vaccine And Therapeutics Sales (K Units) by Application
Table 95. Global mRNA Vaccine And Therapeutics Market Size by Application(M USD)
Table 96. Global mRNA Vaccine And Therapeutics Sales by Application (2020-2033) & (K Units)
Table 97. Global mRNA Vaccine And Therapeutics Sales Market Share by Application (2020-2033)
Table 98. Global mRNA Vaccine And Therapeutics Market Size by Application (2020-2033) & (M USD)
Table 99. Global mRNA Vaccine And Therapeutics Market Share by Application (2020-2033)
Table 100. Global mRNA Vaccine And Therapeutics Sales Growth Rate by Application (2020-2033)
Table 101. Argos Therapeutics Basic Information
Table 102. Argos Therapeutics mRNA Vaccine And Therapeutics Product Overview
Table 103. Argos Therapeutics mRNA Vaccine And Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Argos Therapeutics Business Overview
Table 105. Argos Therapeutics SWOT Analysis
Table 106. Argos Therapeutics Recent Developments
Table 107. BioNTech Basic Information
Table 108. BioNTech mRNA Vaccine And Therapeutics Product Overview
Table 109. BioNTech mRNA Vaccine And Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. BioNTech Business Overview
Table 111. BioNTech SWOT Analysis
Table 112. BioNTech Recent Developments
Table 113. CureVac Basic Information
Table 114. CureVac mRNA Vaccine And Therapeutics Product Overview
Table 115. CureVac mRNA Vaccine And Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. CureVac Business Overview
Table 117. CureVac SWOT Analysis
Table 118. CureVac Recent Developments
Table 119. eTheRNA Basic Information
Table 120. eTheRNA mRNA Vaccine And Therapeutics Product Overview
Table 121. eTheRNA mRNA Vaccine And Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. eTheRNA Business Overview
Table 123. eTheRNA Recent Developments
Table 124. Ethris Basic Information
Table 125. Ethris mRNA Vaccine And Therapeutics Product Overview
Table 126. Ethris mRNA Vaccine And Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Ethris Business Overview
Table 128. Ethris Recent Developments
Table 129. In-Cell-Art Basic Information
Table 130. In-Cell-Art mRNA Vaccine And Therapeutics Product Overview
Table 131. In-Cell-Art mRNA Vaccine And Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. In-Cell-Art Business Overview
Table 133. In-Cell-Art Recent Developments
Table 134. Moderna Therapeutics Basic Information
Table 135. Moderna Therapeutics mRNA Vaccine And Therapeutics Product Overview
Table 136. Moderna Therapeutics mRNA Vaccine And Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Moderna Therapeutics Business Overview
Table 138. Moderna Therapeutics Recent Developments
Table 139. Sangamo Therapeutics Basic Information
Table 140. Sangamo Therapeutics mRNA Vaccine And Therapeutics Product Overview
Table 141. Sangamo Therapeutics mRNA Vaccine And Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Sangamo Therapeutics Business Overview
Table 143. Sangamo Therapeutics Recent Developments
Table 144. Tiba Biotechnology Basic Information
Table 145. Tiba Biotechnology mRNA Vaccine And Therapeutics Product Overview
Table 146. Tiba Biotechnology mRNA Vaccine And Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Tiba Biotechnology Business Overview
Table 148. Tiba Biotechnology Recent Developments
Table 149. Translate Bio Basic Information
Table 150. Translate Bio mRNA Vaccine And Therapeutics Product Overview
Table 151. Translate Bio mRNA Vaccine And Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Translate Bio Business Overview
Table 153. Translate Bio Recent Developments
List of Figures
Figure 1. Product Picture of mRNA Vaccine And Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Vaccine And Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global mRNA Vaccine And Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global mRNA Vaccine And Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Vaccine And Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Vaccine And Therapeutics Product Life Cycle
Figure 13. mRNA Vaccine And Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global mRNA Vaccine And Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market mRNA Vaccine And Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccine And Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of mRNA Vaccine And Therapeutics
Figure 19. Global mRNA Vaccine And Therapeutics Market PEST Analysis
Figure 20. Global mRNA Vaccine And Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global mRNA Vaccine And Therapeutics Market Size by Region
Figure 27. Global mRNA Vaccine And Therapeutics Market Size Market Share by Region (2020-2033)
Figure 28. Global mRNA Vaccine And Therapeutics Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America mRNA Vaccine And Therapeutics Market Size (M USD) by Country
Figure 33. USA mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada mRNA Vaccine And Therapeutics Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada mRNA Vaccine And Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico mRNA Vaccine And Therapeutics Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico mRNA Vaccine And Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America mRNA Vaccine And Therapeutics Market Size (M USD)by Type
Figure 40. North America mRNA Vaccine And Therapeutics Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe mRNA Vaccine And Therapeutics Market Size (M USD) by Country
Figure 45. Germany mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe mRNA Vaccine And Therapeutics Market Size (M USD) by Type
Figure 56. Europe mRNA Vaccine And Therapeutics Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific mRNA Vaccine And Therapeutics Market Size (M USD) by Country
Figure 61. China mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific mRNA Vaccine And Therapeutics Market Size (M USD) by Type
Figure 72. Asia-Pacific mRNA Vaccine And Therapeutics Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America mRNA Vaccine And Therapeutics Market Size (M USD) by Country
Figure 77. Brazil mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America mRNA Vaccine And Therapeutics Market Size (M USD) by Type
Figure 84. South America mRNA Vaccine And Therapeutics Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa mRNA Vaccine And Therapeutics Market Size (M USD) by Country
Figure 89. Saudi Arabia mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa mRNA Vaccine And Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa mRNA Vaccine And Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa mRNA Vaccine And Therapeutics Market Size (M USD) by Type
Figure 100. Middle East and Africa mRNA Vaccine And Therapeutics Market Size (M USD) by Application
Figure 101. Global mRNA Vaccine And Therapeutics Production Market Share by Region (2020-2025)
Figure 102. North America mRNA Vaccine And Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe mRNA Vaccine And Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan mRNA Vaccine And Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. China mRNA Vaccine And Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global mRNA Vaccine And Therapeutics Market Size by Type (M USD)
Figure 108. Sales Market Share of mRNA Vaccine And Therapeutics by Type (2020-2033)
Figure 109. Sales Market Share of mRNA Vaccine And Therapeutics by Type in 2024
Figure 110. Market Size Share of mRNA Vaccine And Therapeutics by Type (2020-2033)
Figure 111. Market Size Share of mRNA Vaccine And Therapeutics by Type in 2024
Figure 112. Global mRNA Vaccine And Therapeutics Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global mRNA Vaccine And Therapeutics Market Size by Application(M USD)
Figure 115. Global mRNA Vaccine And Therapeutics Market Share by Application
Figure 116. Global mRNA Vaccine And Therapeutics Sales Market Share by Application (2020-2033)
Figure 117. Global mRNA Vaccine And Therapeutics Sales Market Share by Application in 2024
Figure 118. Global mRNA Vaccine And Therapeutics Market Share by Application (2020-2033)
Figure 119. Global mRNA Vaccine And Therapeutics Market Share by Application in 2024
Figure 120. Global mRNA Vaccine And Therapeutics Sales Growth Rate by Application (2020-2033)